Colgate-Palmolive (CL) Stock Forecast & Price Target

$88.27 -0.42 (-0.47%)

As of 01/21/2025 03:59 PM Eastern

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
1

Hold
9

Buy
12

Based on 22 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 9 have given a hold rating, and 12 have given a buy rating for CL.

Consensus Price Target

$101.11
14.54% Upside

According to the 22 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $101.11. The highest price target for CL is $112.00, while the lowest price target for CL is $83.00. The average price target represents a forecasted upside of 14.54% from the current price of $88.27.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

CL Analyst Ratings Over Time

Type	Current Forecast 1/23/24 to 1/22/25	1 Month Ago 12/24/23 to 12/23/24	3 Months Ago 10/25/23 to 10/24/24	1 Year Ago 1/23/23 to 1/23/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)	9 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$101.11	$105.11	$106.00	$84.93
Forecasted Upside	14.54% Upside	14.36% Upside	6.27% Upside	4.32% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.50	2.49	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	14.54% Upside	46.10% Upside	11.17% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/17/2025	Stifel Nicolaus 4 of 5 stars	Mark Astrachan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$101.00 ➝ $95.00	+6.34%
1/17/2025	Barclays 3 of 5 stars	Lauren Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$96.00 ➝ $83.00	-6.70%
1/16/2025	UBS Group 4 of 5 stars	Peter Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$112.00 ➝ $104.00	+17.99%
1/16/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$109.00 ➝ $103.00	+17.18%
1/8/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$110.00 ➝ $100.00	+14.53%
1/7/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Underweight ➝ Underweight	$92.00 ➝ $83.00	-5.98%
1/6/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$121.00 ➝ $112.00	+27.01%
9/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$107.00 ➝ $109.00	+1.06%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$100.00 ➝ $103.00	+3.00%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
7/29/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$103.00 ➝ $111.00	+10.46%
7/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Zamacona Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$103.00 ➝ $95.00	-1.61%
7/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $106.00	+6.91%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$103.00 ➝ $112.00	+15.00%
7/10/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+13.26%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%
5/15/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Graja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $107.00	+13.01%
4/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$88.00 ➝ $95.00	+4.38%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$93.00	+7.50%
1/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$91.00	+9.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:52 AM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, January 12, 2025. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

Colgate-Palmolive has a strong market capitalization of approximately $75.19 billion, indicating a solid financial foundation and stability, which can be attractive to investors looking for reliable companies.
The company recently announced a quarterly dividend of $0.50 per share, translating to an annualized dividend of $2.00 and a dividend yield of 2.17%. This consistent dividend payment can provide a steady income stream for investors.
Colgate-Palmolive's stock price is currently around $94.11, which is near its 50-day simple moving average of $95.02, suggesting that the stock is trading within a stable range and may present a good entry point for potential investors.
Analysts have given Colgate-Palmolive a consensus price target of $105.11, indicating potential upside from the current stock price, which could attract investors looking for growth opportunities.
The company has a relatively low beta of 0.43, suggesting that it is less volatile than the market. This can be appealing to risk-averse investors seeking stability in their portfolios.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

Colgate-Palmolive has a high debt-to-equity ratio of 9.46, indicating that the company relies heavily on debt financing. This could pose risks, especially in a rising interest rate environment.
Recent insider trading activity shows that the CFO sold a significant number of shares, which could signal a lack of confidence in the company's future performance from its leadership.
The company's PEG ratio stands at 3.31, which is relatively high. This suggests that the stock may be overvalued compared to its earnings growth potential, making it less attractive for value investors.
Brokerage ratings have been mixed, with some firms downgrading their ratings and price targets, indicating uncertainty about the company's future performance in the market.
Colgate-Palmolive's recent trading volume of 5,063,919 shares is above its average volume, which could indicate increased selling pressure and volatility, potentially deterring conservative investors.

CL Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $101.11, with a high forecast of $112.00 and a low forecast of $83.00.
: 22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There is currently 1 sell rating, 9 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.
: According to analysts, Colgate-Palmolive's stock has a predicted upside of 14.54% based on their 12-month stock forecasts.
: Over the previous 90 days, Colgate-Palmolive's stock had 1 downgrade by analysts.
: Colgate-Palmolive has been rated by research analysts at Barclays, JPMorgan Chase & Co., Piper Sandler, Stifel Nicolaus, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:CL) was last updated on 1/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target